These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3716619)

  • 1. [Blood aluminum levels in workers in the aluminum industry].
    Schlatter C; Steinegger A; Rickenbacher U; Hans C; Lengeyl A
    Soz Praventivmed; 1986; 31(2):125-9. PubMed ID: 3716619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum aluminium levels of workers in the bauxite mines.
    de Kom JF; Dissels HM; van der Voet GB; de Wolff FA
    J Toxicol Clin Toxicol; 1997; 35(6):645-51. PubMed ID: 9365435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behaviour of biological indicators of internal dose and some neuro-endocrine tests in aluminium workers.
    Alessio L; Apostoli P; Ferioli A; Di Sipio I; Mussi I; Rigosa C; Albertini A
    Med Lav; 1989; 80(4):290-300. PubMed ID: 2593966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and dialysate aluminium concentration of dialysed patients with chronic renal failure determined by atomic absorption spectrometry with a graphite furnace.
    Mazzeo-Farina A; Cerulli N
    Clin Chim Acta; 1985 Apr; 147(3):247-54. PubMed ID: 3995774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detecting and evaluating hyperaluminemia in 3 dialysis centers].
    Balabán D; Simícková J; Kubátko J; Syrovátka P
    Cas Lek Cesk; 1989 Dec; 128(51):1611-4. PubMed ID: 2631999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyperaluminemia in chronic hemodialysis patients. Evaluation of the respective roles of dialysate aluminum and oral aluminum hydroxide].
    Tahiri Y; Moriniere P; Jaudon MC; Dkhissi H; Rosa A; Fournier A
    Nephrologie; 1983; 4(3):129-33. PubMed ID: 6633778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum aluminium level in the veneto chronic haemodialysis population: cross-sectional study on 1,026 patients.
    Piccoli A; Andriani M; Mattiello G; Nordio M; Modena F; Dalla Rosa C
    Nephron; 1989; 51(4):482-90. PubMed ID: 2787000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of the plasma aluminum concentration of hemodialysis patients].
    Kuleva V; Petrov I; Antonov S; Kiriakov Z
    Vutr Boles; 1984; 23(2):51-5. PubMed ID: 6741112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Level-dependent inhibitory effect of hyperaluminaemia on parathyroid hormone secretion in patients with end-stage renal failure.
    Fernández E; Amoedo ML; Montoliu J
    Eur J Med; 1992 Dec; 1(8):482-4. PubMed ID: 1341207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of aluminium mobilization in renal dialysis patients using the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.
    Kontoghiorghes GJ; Barr J; Baillod RA
    Arzneimittelforschung; 1994 Apr; 44(4):522-6. PubMed ID: 8011008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomedical aspects of aluminium.
    Schlatter C
    Med Lav; 1992; 83(5):470-4. PubMed ID: 1297060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newcastle bone disease in Hong Kong: a study of aluminum associated osteomalacia.
    Chan MK; Varghese Z; Li MK; Wong WS; Li CS
    Int J Artif Organs; 1990 Mar; 13(3):162-8. PubMed ID: 2189835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey of blood lead and plasma aluminium concentrations in patients of a renal unit.
    Sampson B; Curtis JR; Davies S
    Nephrol Dial Transplant; 1989; 4(5):375-81. PubMed ID: 2505188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aluminium uptake and excretion in potroom workers of a new primary aluminium smelter during the construction stage.
    Röllin HB; Theodorou P; Nogueir CM; Levin J
    J Environ Monit; 2001 Dec; 3(6):560-4. PubMed ID: 11785626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect on serum aluminium levels of continued ingestion of aluminium gels by patients with chronic renal insufficiency (author's transl)].
    Boukari M; Rottembourg J; Jaudon MC; Clavel JP; Legrain M; Galli A
    Nouv Presse Med; 1978 Jan; 7(2):85-8. PubMed ID: 349501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and urinary aluminium levels of workers in the aluminium industry.
    Gitelman HJ; Alderman FR; Kurs-Lasky M; Rockette HE
    Ann Occup Hyg; 1995 Apr; 39(2):181-91. PubMed ID: 7741415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aluminium kinetics during haemodialysis with the Redy 2000 Sorbsystem.
    Curtis JR; Sampson B
    Int J Artif Organs; 1989 Nov; 12(11):683-7. PubMed ID: 2599666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects on the nervous system in different groups of workers exposed to aluminium.
    Iregren A; Sjögren B; Gustafsson K; Hagman M; Nylén L; Frech W; Andersson M; Ljunggren KG; Wennberg A
    Occup Environ Med; 2001 Jul; 58(7):453-60. PubMed ID: 11404450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aluminium in chronic renal replacement therapy patients undergoing haemodialysis in two renal units in Bogotá].
    Cárdenas O; Segura O; Puentes W; Sanabria M; Nava G; Torrenegra R
    Rev Salud Publica (Bogota); 2010 Aug; 12(4):669-81. PubMed ID: 21340131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of alveolar cells and soluble components in bronchoalveolar lavage fluid from non-smoking aluminium potroom workers.
    Eklund A; Arns R; Blaschke E; Hed J; Hjertquist SO; Larsson K; Löwgren H; Nyström J; Sköld CM; Tornling G
    Br J Ind Med; 1989 Nov; 46(11):782-6. PubMed ID: 2556178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.